Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

anti-PSMA monoclonal antibody MLN591-DM1 immunoconjugate MLN2704

An immunoconjugate that consists of a humanized monoclonal antibody (MLN591), directed against prostate-specific membrane antigen linked to a maytansinoid (DM1). The monoclonal antibody moiety of MLN2704 binds to tumor cells expressing prostate-specific membrane antigen; MLN274 is then internalized into the tumor cell where the DM1 maytansinoid moiety binds to tubulin and inhibits tubulin polymerization and microtubule assembly, resulting in a disruption of microtubule activity and cell division, and cell death.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:DM1-conjugated monoclonal antibody MLN591
maytansinoid -1 conjugated with MLN591 monoclonal antibody
Code name:MLN591DM1
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search